BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 36563685)

  • 1. CFIm-mediated alternative polyadenylation safeguards the development of mammalian pre-implantation embryos.
    Li N; Cai Y; Zou M; Zhou J; Zhang L; Zhou L; Xiang W; Cui Y; Li H
    Stem Cell Reports; 2023 Jan; 18(1):81-96. PubMed ID: 36563685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nudt21 regulates the alternative polyadenylation of Pak1 and is predictive in the prognosis of glioblastoma patients.
    Chu Y; Elrod N; Wang C; Li L; Chen T; Routh A; Xia Z; Li W; Wagner EJ; Ji P
    Oncogene; 2019 May; 38(21):4154-4168. PubMed ID: 30705404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CFIm-mediated alternative polyadenylation remodels cellular signaling and miRNA biogenesis.
    Ghosh S; Ataman M; Bak M; Börsch A; Schmidt A; Buczak K; Martin G; Dimitriades B; Herrmann CJ; Kanitz A; Zavolan M
    Nucleic Acids Res; 2022 Apr; 50(6):3096-3114. PubMed ID: 35234914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SRSF3 and SRSF7 modulate 3'UTR length through suppression or activation of proximal polyadenylation sites and regulation of CFIm levels.
    Schwich OD; Blümel N; Keller M; Wegener M; Setty ST; Brunstein ME; Poser I; Mozos IRL; Suess B; Münch C; McNicoll F; Zarnack K; Müller-McNicoll M
    Genome Biol; 2021 Mar; 22(1):82. PubMed ID: 33706811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-messenger RNA cleavage factor I (CFIm): potential role in alternative polyadenylation during spermatogenesis.
    Sartini BL; Wang H; Wang W; Millette CF; Kilpatrick DL
    Biol Reprod; 2008 Mar; 78(3):472-82. PubMed ID: 18032416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor β1 alters the 3'-UTR of mRNA to promote lung fibrosis.
    Ko J; Mills T; Huang J; Chen NY; Mertens TCJ; Collum SD; Lee G; Xiang Y; Han L; Zhou Y; Lee CG; Elias JA; Jyothula SSK; Rajagopal K; Karmouty-Quintana H; Blackburn MR
    J Biol Chem; 2019 Oct; 294(43):15781-15794. PubMed ID: 31488543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging roles of CFIm25 (NUDT21/CPSF5) in human biology and disease.
    Masamha CP
    Wiley Interdiscip Rev RNA; 2023; 14(3):e1757. PubMed ID: 35965101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NUDT21 alters glioma migration through differential alternative polyadenylation of LAMC1.
    Jonnakuti VS; Ji P; Gao Y; Lin A; Chu Y; Elrod N; Huang KL; Li W; Yalamanchili HK; Wagner EJ
    J Neurooncol; 2023 Jul; 163(3):623-634. PubMed ID: 37389756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APA-Scan: detection and visualization of 3'-UTR alternative polyadenylation with RNA-seq and 3'-end-seq data.
    Fahmi NA; Ahmed KT; Chang JW; Nassereddeen H; Fan D; Yong J; Zhang W
    BMC Bioinformatics; 2022 Sep; 23(Suppl 3):396. PubMed ID: 36171568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NUDT21 inhibits bladder cancer progression through ANXA2 and LIMK2 by alternative polyadenylation.
    Xiong M; Chen L; Zhou L; Ding Y; Kazobinka G; Chen Z; Hou T
    Theranostics; 2019; 9(24):7156-7167. PubMed ID: 31695759
    [No Abstract]   [Full Text] [Related]  

  • 11. NUDT21 regulates 3'-UTR length and microRNA-mediated gene silencing in hepatocellular carcinoma.
    Sun M; Ding J; Li D; Yang G; Cheng Z; Zhu Q
    Cancer Lett; 2017 Dec; 410():158-168. PubMed ID: 28964783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Cancer-Specific Ubiquitin Ligase Drives mRNA Alternative Polyadenylation by Ubiquitinating the mRNA 3' End Processing Complex.
    Yang SW; Li L; Connelly JP; Porter SN; Kodali K; Gan H; Park JM; Tacer KF; Tillman H; Peng J; Pruett-Miller SM; Li W; Potts PR
    Mol Cell; 2020 Mar; 77(6):1206-1221.e7. PubMed ID: 31980388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The microRNA target site landscape is a novel molecular feature associating alternative polyadenylation with immune evasion activity in breast cancer.
    Kim S; Bai Y; Fan Z; Diergaarde B; Tseng GC; Park HJ
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32844230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knock-down of 25 kDa subunit of cleavage factor Im in Hela cells alters alternative polyadenylation within 3'-UTRs.
    Kubo T; Wada T; Yamaguchi Y; Shimizu A; Handa H
    Nucleic Acids Res; 2006; 34(21):6264-71. PubMed ID: 17098938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential role for phosphorylation in alternative polyadenylation function versus nuclear import of SR-like protein CPSF6.
    Jang S; Cook NJ; Pye VE; Bedwell GJ; Dudek AM; Singh PK; Cherepanov P; Engelman AN
    Nucleic Acids Res; 2019 May; 47(9):4663-4683. PubMed ID: 30916345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LINC00921 reduces lung cancer radiosensitivity by destabilizing NUDT21 and driving aberrant MED23 alternative polyadenylation.
    Zhang N; Liu X; Huang L; Zeng J; Ma C; Han L; Li W; Yu J; Yang M
    Cell Rep; 2023 Dec; 42(12):113479. PubMed ID: 37999979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative polyadenylation reprogramming of MORC2 induced by NUDT21 loss promotes KIRC carcinogenesis.
    Tan Y; Zheng T; Su Z; Chen M; Chen S; Zhang R; Wang R; Li K; Na N
    JCI Insight; 2023 Sep; 8(18):. PubMed ID: 37737260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Cleavage and Polyadenylation Specificity Factor 6 (CPSF6) Subunit of the Capsid-recruited Pre-messenger RNA Cleavage Factor I (CFIm) Complex Mediates HIV-1 Integration into Genes.
    Rasheedi S; Shun MC; Serrao E; Sowd GA; Qian J; Hao C; Dasgupta T; Engelman AN; Skowronski J
    J Biol Chem; 2016 May; 291(22):11809-19. PubMed ID: 26994143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitously transcribed genes use alternative polyadenylation to achieve tissue-specific expression.
    Lianoglou S; Garg V; Yang JL; Leslie CS; Mayr C
    Genes Dev; 2013 Nov; 27(21):2380-96. PubMed ID: 24145798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative polyadenylation of single cells delineates cell types and serves as a prognostic marker in early stage breast cancer.
    Kim N; Chung W; Eum HH; Lee HO; Park WY
    PLoS One; 2019; 14(5):e0217196. PubMed ID: 31100099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.